VC

Investor profile

LIFTT logo

LIFTT

ITFRGBUSFIDKATBEOtherDeep TechHealthtechBio/PharmaAI/MLClimateEnterpriseOther

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

LIFTT is a venture capital holding company focused on deep tech, with a hands-on, multi-sector approach aimed at creating meaningful impact. Founded in 2019 by Compagnia di San Paolo, Politecnico di Torino, and LINKS Foundation, and chaired by physicist-entrepreneur Stefano Buono, LIFTT's mission is to turn outstanding scientific research into high-impact businesses, speeding up the journey from lab to market. The firm invests from the earliest stages — pre-seed through Series A — across four strategic verticals: Critical Resources, Human Health & Aging, Infrastructure for the Data Revolution, and Energy Security & Industrial Automation. LIFTT targets breakthrough technologies in hardware B2B deep tech fields such as quantum computing, photonics, semiconductors, advanced materials, and life sciences, emphasising unique intellectual property and exceptional scientific teams. Beyond capital, LIFTT provides managerial coaching, governance guidance, and access to a curated international network of over 200 private and institutional investors. Active across Europe with a global outlook, LIFTT has raised over €104.7 million, completed more than 50 investments, and in 2024 established LIFTT EuroInvest — a €100 million joint vehicle with the European Investment Bank — to further scale equity investments in innovative Italian and European companies.

Notable quotes

Our collaboration with the EIC has been a key driver of innovation, allowing us to expand our portfolio and contribute to the growth of a dynamic and collaborative European deep-tech ecosystem. We look forward to continuing this shared mission of supporting groundbreaking innovation and turning research into market-ready solutions.

Giovanni Tesoriere · EIC Fund – European Innovation Council website (eic.ec.europa.eu)

This exit represents a significant achievement for LIFTT and highlights our commitment to supporting the development of new solutions for cancer patients and our dedication to an increasingly strategic sector for human health.

Giovanni Tesoriere · LinkedIn post by LIFTT (@liftt-spa) on Evergreen Theragnostics exit · 2025-01-28

We promote research, invest in a network of shared knowledge, reward skills and believe in the positive effects that every company can and must generate in the area in which it operates.

Stefano Buono · LIFTT homepage (liftt.com)

Recent investments

CompanyRoundSizeDate
Wearable RoboticsSeries A$6m2026-04-03
CareGlanceSeed$4m2026-04-09
VitrealabSeries A$11m2026-01-07
Sparrow QuantumSeries A$32m2025-12-01
RAAAM Memory TechnologiesSeries A$18m2025-11-09
CellplySeries A$7m2025-06-01
NewcleoSeries B+2022-01-01
Electra Vehicles (Electra AI)Seed2021-01-01
Evergreen TheragnosticsSeries C2024-04-16
MicroLubSeed$4m2024-01-01

Frequent co-investors

Fit check

Is LIFTT a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit